GENSCRIPT BIO(01548): Legend to present latest data at the American Society of Hematology annual meeting.

date
07:42 04/11/2025
avatar
GMT Eight
Kingstron Biotech (01548) announced that Legendary Biotech Co., Ltd. (a joint venture of the company, its shares...)
GENSCRIPT BIO (01548) announced that Legend Biotech Corporation (a company affiliated with the company, whose shares are listed on the Nasdaq Global Select Market in the form of American Depositary Shares) submitted a Form 6-K to the U.S. Securities and Exchange Commission on November 3, 2025 (New York time) (prior to the Hong Kong trading hours on November 4, 2025), and announced that it will present the latest data related to CARVYKTI and other pipelines at the 67th Annual Meeting of the American Society of Hematology, to be held in San Diego from December 6 to 9, 2025.